Effect of vitamin supplementation in pregnancy on infant growth; parallel randomised controlled studies in vitamin D deficient and replete wome
Not Applicable
Completed
- Conditions
- Obstetrics and gynaecologyPregnancy and Childbirth
- Registration Number
- ISRCTN11812357
- Lead Sponsor
- Medical Research Council (MRC) (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 0
Inclusion Criteria
Not provided at time of registration.
Exclusion Criteria
Not provided at time of registration.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ot provided at time of registration.
- Secondary Outcome Measures
Name Time Method ot provided at time of registration.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
How does maternal vitamin D supplementation during pregnancy influence fetal growth through VDR signaling pathways?
What is the comparative effectiveness of high-dose vs. standard-dose vitamin D supplementation in preventing neonatal growth deficits?
Which biomarkers, such as serum 25(OH)D levels or VDR polymorphisms, predict optimal response to vitamin D supplementation in pregnant women?
What are the potential adverse events associated with vitamin D supplementation in pregnancy, and how are they managed in clinical practice according to ISRCTN11812357?
Are there combination therapies involving vitamin D and other nutrients (e.g., calcium, DHA) that enhance infant growth outcomes in prenatal care?